Trusted by Thousands of Patients "The NAD IV is well worth it
The FDA has issued safety communications regarding compounded GLP-1 receptor agonists, including tirzepatide and semaglutide, warning about adverse events from bacterial contamination, incorrect dosing, and use of improper ingredients
Its concerning that several members of the newly formulated [committee] appear to sell unproven offerings including stem cells and peptides, sometimes both, said Paul Knoepfler, a professor of cell biology and human anatomy at UC Davis School of Medicine and a STAT contributor
Gentle, wall-directed addition protects the peptide structure
According to investment bank Jefferies, the weight-loss drugs market could be worth $1 billion in domestic sales alone, driven almost entirely by injectable GLP-1s